Aeterna Zentaris is focused on serving the unmet medical needs of patients with rare endocrine diseases through acquisition, development and licensing orphan products.
Our vision for the future focuses on leveraging our global endocrinology expertise acquired through clinical development of macimorelin to establish a value driven product portfolio for endocrinology orphan diseases through acquisition of marketed and development-stage medicines and/or in- and out-licensing activities. Our business development team is constantly looking for new opportunities to make strategic deals that benefit our patients, our partners and our shareholders.
Aeterna Zentaris has a set of core values that guides all of our activities. We pledge to act with Integrity — comprising Fairness, Honesty and Perseverance especially when facing difficulties or challenges. In our everyday work, we focus on the following values while upholding the highest ethical standards: Teamwork, Transparency, Innovation, Integrity.